Head-to-head · WeighScore
OurView Health vs Ozari Health
The verdict
Ozari Health takes it — 68.9/100 to 67.6/100, but only just.
Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform selling physician-prescribed compounded GLP-1 from licensed 503A/503B pharmacies. OurView Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | OurView Health | Ozari Health |
|---|---|---|
| WeighScore | 67.6/100 | 68.9/100 |
| Grade | C | C |
| Scorecard rank | #162 | #136 |
| Semaglutide | $75/mo (starting dose, compounded) | $86/mo (3-mo starter plan, new patients only, compounded) |
| Tirzepatide | $135/mo (starting dose, compounded) | $125/mo (3-mo starter plan, new patients only, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #162 · C
Strengths
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
- Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)
Where it loses points
- A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
- Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #136 · C
Strengths
- Very low entry pricing — compounded semaglutide from $86/month
- LegitScript certified and operated by a named entity (Ozari LLC)
- Board-certified physicians; meds compounded in 503A and 503B facilities
- Shipping included in the plan price
Where it loses points
- The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
- Cancelling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.